GDRX
Goodrx Holdings, Inc. Information Technology Services-Computer Processing & Data Preparation Russell 3000
$3.49Close
$1.87 – $3.8052-week range
Nov 3, 2026Next report
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
Cautions
- Earnings shrinking EPS −32% year on year
- Results soon Nov 3, 2026, in 2 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
8%
1wk
down 1.4%
price change
1mo
up 6.1%
price change
12-month return
up 1%
market up 11% ·
its own down 12%
F-score
—
— Not assessed
Altman Z″
-0.18
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
—
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
up 1%
year on year
EPS growth
down 32%
latest quarter · +56 pts
Sales growth
down 1%
latest quarter · +3 pts
ROE
up 5%
return on equity
Free cash margin
up 21%
$164.4M FCF
D/E
0.78
long-term debt / equity
Net debt / EBITDA
1.3×
Interest cover
—EBIT / interest
Trade setup
ATR%
3.5%
$0.12 a day · 2×ATR $3.24
RS
79 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
1.4×
vs 50-day average
Up/down volume
1.19
50 sessions
Implied move
—
no option chain · report Nov 3, 2026
Trend template · 8 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
Last reported
Aug 5, 2026
Results reaction
Aug 5, 2026+12% vs market2 sessions after results
Financials
- Net 4%
- Free cash 21%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $550.7M | $745.4M | $766.6M | $750.3M | $792.3M | $796.9M |
| Operating income | -$275.7M | $13.4M | $1.7M | -$27.0M | $65.8M | $87.5M |
| Net income | -$293.6M | -$25.3M | -$32.8M | -$8.9M | $16.4M | $30.4M |
| Net margin | -53% | -3% | -4% | -1% | 2% | 4% |
| Earnings per share | -$1.07 | -$0.06 | -$0.08 | -$0.02 | $0.04 | $0.09 |
| Free cash flow | $110.8M | $174.2M | $142.8M | $137.2M | $182.7M | $164.4M |
| Free cash margin | 20% | 23% | 19% | 18% | 23% | 21% |
| Cash | $968.7M | $941.1M | $757.2M | $672.3M | $448.3M | $261.8M |
| Long-term debt | $659.9M | $655.9M | $651.8M | $647.7M | $486.7M | $483.3M |
| Shareholders' equity | $711.4M | $831.7M | $814.8M | $762.0M | $724.7M | $616.3M |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 5, 2026 | Quarterly ↗ | Jun 30, 2026 | 36d |
| May 6, 2026 | Quarterly ↗ | Mar 31, 2026 | 36d |
| Feb 26, 2026 | Annual ↗ | Dec 31, 2025 | 57d |
| Nov 4, 2025 | Quarterly ↗ | Sep 30, 2025 | 35d |
| Aug 6, 2025 | Quarterly ↗ | Jun 30, 2025 | 37d |
| May 7, 2025 | Quarterly ↗ | Mar 31, 2025 | 37d |
| Feb 27, 2025 | Annual ↗ | Dec 31, 2024 | 58d |
| Nov 7, 2024 | Quarterly ↗ | Sep 30, 2024 | 38d |
| Aug 8, 2024 | Quarterly ↗ | Jun 30, 2024 | 39d |
| May 9, 2024 | Quarterly ↗ | Mar 31, 2024 | 39d |
| Feb 29, 2024 | Annual ↗ | Dec 31, 2023 | 60d |
| Nov 9, 2023 | Quarterly ↗ | Sep 30, 2023 | 40d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 5, 2026 | Director or officer change ↗ |
| Aug 5, 2026 | Results ↗ |
| Jun 18, 2026 | Shareholder vote ↗ |
| May 6, 2026 | Results ↗ |
| Apr 24, 2026 | Director or officer change ↗ |
| Apr 3, 2026 | Director or officer change ↗ |
| Mar 27, 2026 | Director or officer change ↗ |
| Mar 18, 2026 | Auditor change ↗ |
| Mar 6, 2026 | Director or officer change ↗ |
| Feb 27, 2026 | Director or officer change ↗ |
| Feb 25, 2026 | Results ↗ |
| Dec 12, 2025 | Director or officer change ↗ |